logo

For the Inventor, By the Inventor

Shanghai, China

Yongyong Shi

This inventor holds 13 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Shanghai Jiao Tong University, Shandong Shanda Hospital for Reproductive Medicine Co., Ltd., Shandong University. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yongyong Shi. Retrieved from https://idiyas.com/inventor/yongyong-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal13 out of 413 
 
Shanghai Jiao Tong University
 patents
silverMedal1 out of 1 
 
Shandong Shanda Hospital for Reproductive Medicine Co., Ltd.
 patent
bronzeMedal1 out of 366 
 
Shandong University
 patents
where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12427139 - Applications for nicardipine in preparing anti-lung cancer products (2025-09-30),
2. 11925628 - Applications for nicardipine in preparing anti-lung cancer products (2024-03-12),
3. 11903914 - Applications for sulindac in preparing anti-lung cancer products (2024-02-20),
4. 11452730 - Applications of desogestrel in the preparation of breast cancer ER-negative Ah receptor-positive products (2022-09-27),
5. 11273165 - Applications for estradiol in preparing anti-small cell lung cancer and/or ovarian cancer and/or osteosarcoma products (2022-03-15),
6. 11197865 - Applications for promethazine in preparing anti-liver cancer and/or colon cancer and/or lung cancer products (2021-12-14),
7. 11045436 - Applications for sulindac in preparing anti-lung cancer products (2021-06-29),
8. 10864220 - Applications of desogestrel in the preparation of anti-colon cancer/breast cancer ER-negative Ah receptor-positive products (2020-12-15),
9. 10792291 - Applications for levonorgestrel in preparing anti-ovarian cancer products (2020-10-06),
10. 10653705 - Applications for estrone in preparing anti-ovarian cancer and/or breast cancer products (2020-05-19),
11. 10441591 - Applications for etonogestrel in preparing anti-prostate cancer products (2019-10-15),
12. 10292988 - Applications for estrone in preparing anti-ovarian cancer and/or breast cancer products (2019-05-21),
13. 8685647 - SNP markers associated with polycystic ovary syndrome (2014-04-01),

Title: The Innovative Journey of Inventor Yongyong Shi

Introduction: Yongyong Shi is a pioneering inventor hailing from Shanghai, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yongyong Shi holds several patents in the realm of artificial intelligence, robotics, and renewable energy, showcasing his continuous dedication to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Yongyong Shi has worked with prestigious research institutions and leading tech companies, where he has spearheaded projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Yongyong Shi has collaborated with top engineers, scientists, and researchers from around the globe, fostering a culture of innovation and knowledge exchange that has led to remarkable breakthroughs in various fields.

Conclusion: Yongyong Shi's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his position as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…